Biologic API Sourcing Center
Active Pharmaceutical Ingredients (API) for biologics can at times be somewhat more complicated than small-molecule API, involving both sophisticated culture and fermentation of microorganisms as well as chemical compounds and processes.
High degrees of purity and process controls must be maintained in facilities capable of handling large molecules. As biologic products continue to reach commercial acceptance, the needs for capacity and specific capabilities will increase, as will the art and science of developing API.
How can we help?
Looking for help with your Biologic API project? If you're searching for information or a supplier, let Life Science Connect lend you a hand.
Biologic API CMOs
Abzena
Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule.
Boehringer Ingelheim Biopharmaceuticals GmbH
Boehringer Ingelheim BioXcellence™ is a top biopharmaceutical contract manufacturer, offering end-to-end solutions from development to global supply. With 40+ years of experience, we deliver cGMP-compliant manufacturing for diverse molecules via mammalian and microbial systems, covering all stages including aseptic filling. Our global facilities support reliable clinical and commercial production, helping bring 45+ biopharmaceuticals to market. Let’s transform your innovation into commercial success together.
Catalent
Catalent is a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products.
Have questions about selecting the right CMO?
The Life Science Connect team can help. We'll match your needs with the right companies.
Contact us via email for assistance.
Coriolis Pharma
Coriolis Pharma, a global science-driven CRDO, offers integrated services in drug product development, analytical testing, and manufacturing support for liquid, frozen-liquid, and lyophilized formats—from early development through commercialization and lifecycle management.
Capabilities
Curia
Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 27 global sites, and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities.
Capabilities
FUJIFILM Biotechnologies
FUJIFILM Biotechnologies is a CDMO Partner for Life. We combine technical leadership in cell culture, microbial fermentation and advanced therapies with world class cGMP manufacturing facilities and superior program management to advance tomorrow's medicines.
IDT Biologika
IDT Biologika is a global CDMO for Innovative Vaccines, Cell & Gene Therapeutics and Aseptic Fill-Finish of other biologics. We offer clients a single source CDMO partner at our sites in Germany and the USA, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. This includes Process Development, Drug Substance Manufacturing, Sterile Dosage Fill-Finish, Labelling & Packaging, Quality Control & Analytics.
Lonza
Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our unparalleled breadth of offerings enables our customers to commercialize their discoveries and innovations in the healthcare industry.
LOTTE Biologics
LOTTE Biologics is a global CDMO delivering integrated biologics and bioconjugate services across the full product lifecycle. Our Dual Hub Service model in the United States and South Korea strengthens supply chain security, enables scalable manufacturing, and ensures consistent quality. We provide phase-appropriate mammalian drug substance manufacturing and fully integrated antibody conjugate capabilities, serving as a trusted long-term partner for advanced biologic and bioconjugate programs.
Capabilities
Mabion
Mabion is a fully integrated CDMO located in central Europe that offers an “end-to-end” solution, covering all stages of drug development: from early clone selection and small-scale manufacturing through process scale-up, large-scale manufacturing, and quality control down to sterile fill-finish, packaging and serialization, bioanalytics, and regulatory support. Broad capabilities and experienced staff make Mabion a perfect long-term partner for any project involving therapeutic proteins.
Novartis Contract Manufacturing
Novartis Contract Manufacturing is a fully integrated CDMO offering end-to-end manufacturing solutions for mammalian, microbial, advanced therapies (pDNA, mRNA, siRNA, autologous cell therapies, viral vectors), oligonucleotides, drug product, device assembly and packaging to meet our clients clinical and commercial supply needs.
Capabilities
ProBio
ProBio is a global CDMO offering customizable end-to-end services from discovery to GMP for plasmids, antibodies, and cell & gene therapies. We bring together multidisciplinary expertise to accelerate the manufacturing of advanced therapies and empower our clients through collaborative, customized, and comprehensive services.
Capabilities
ReciBioPharm
ReciBioPharm is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialise advanced therapy medicinal products (ATMPs). ReciBioPharm’s specialised CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.
Capabilities
Resilience, LLC.
Resilience is a North American contract development and manufacturing organization (CDMO) focused on delivering high-quality, scalable manufacturing solutions for advanced therapies. With capabilities spanning biologics drug substance, cell-based therapies, and aseptic drug product manufacturing for both small and large molecules, Resilience partners with leading biopharma companies to bring complex medicines to market faster and more reliably.
Samsung Biologics
Samsung Biologics is a full-service provider offering development and cGMP manufacturing services. We deliver a broad range of services from development and manufacturing to fill and finish, covering both clinical molecules and commercial products.
SGS
SGS supports clients from discovery to clinical development and commercialization through a comprehensive scope of expert-led QC testing solutions for raw materials, APIs and finished products. With a focus on innovation and quality excellence, SGS has vast experience supporting a variety of product types ranging from small molecule products to complex biologics such as proteins, peptides, monoclonal Antibodies, Antibody-Drug Conjugates, Cell & Gene Therapies and more.
Capabilities